Abstract:Shuang Wang, 1– 4, &ast Xuexia Liu, 5 Xinhua Lin, 1– 4, &ast Xiaojing Lv, 2– 4 Hua Zhang 2– 4 1 School of Clinical Medicine, Shandong Second Medical University, Weifang, People's Republic of China; 2 Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China; 3 Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China; 4 Yantai Key Laboratory of Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China; 5 Shandong Stem Cell Engineering Technology Research Center, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xuexia Liu; Hua Zhang, Department of Otorhinolaryngology & Head and Neck Surgery, Yuhuangding Hospital Affiliated to Qingdao University, No. 20 East, Yuhuangding Road, Yantai, Shandong, 264000, People's Republic of China, Tel +86-15154502782, Email ; Allergic rhinitis (AR), which presents symptoms like sneezing and a runny nose, is categorized as an upper respiratory condition of type 2. Recent progress in comprehending AR has revealed the significant role played by type 2 cytokines, specifically interleukin (IL)-13, IL-4, and IL-5. These cytokines are released by helper T cells 2 (Th2) and innate lymphoid cells (ILC2s). ILC2s have the ability to interact with various immune cells and are essential in promoting both type 2 immune response and tissue repair, contributing to normal homeostatic functions within the body. This article presents a summary of the latest advancements in comprehending the activity of ILC2s, with particular emphasis on their potential role involvement in AR. It explores how they collaborate with Th2 cells to exacerbate nasal inflammation and interact with regulatory T cells (Tregs) to counteract the suppressive role mediated by Tregs during allergic inflammation. The significance of ILC2s in allergen-specific therapy is highlighted. A comprehensive understanding of ILC2s biology establishes a robust foundation for unraveling the pathogenesis of AR and devising innovative therapeutic approaches for its management. Keywords: allergic rhinitis, group 2 innate lymphoid cells, cytokines, Treg cells, Th2 cells The characteristic indications of allergic rhinitis consist of sneezing, nasal blockage, itching in the nose and a runny nose. These symptoms are activated by breathing in allergens and managed by immunoglobulin E (IgE), which results in an increase of Th2 cells and type 2 cytokines within the nasal mucosa. AR is a prevalent global allergic disease. 1–3 Group 2 innate lymphoid cells (ILC2s) play a crucial role in the establishment and preservation of immunity, alongside conventional Th2 cells. This diverse group of innate immune cells is indispensable for immune system functionality. 4,5 ILCs predominantly reside in mucosal tissues and exhibit rapid responsiveness towards environmental pathogens and damage. Upon being activated, ILCs release substantial quantities of cytokines, attract additional immune and inflammatory cells, trigger the activation of adaptive immune cells, and facilitate physiological as well as pathological responses. 6,7 There are three primary categories of ILCs that can be distinguished: ILC1s, ILC2s, and ILC3s. 5,7,8 The activity of ILC1s is regulated by a specific transcription factor known as T-box transcription factor. This regulation leads to the release of IFN-a and TNF-y when IL-1, IL-15, and IL-11 are activated. 6,7 GATA-binding protein 3 (GATA3) plays a crucial role in controlling the function of ILC2s, 9,10 resulting in the secretion of cytokines similar to Th2 cells such as IL-13 and IL-5. Activation of either IL-23 or IL-1β triggers the release of both IL-22 and IL-17 from ILC3s. 11–13 Numerous studies have indicated an increase in ILC2s among individuals with AR as well as mouse models. 14–16 These findings suggest that ILC2s may play a positive role in the development of AR.Hence, it is crucial to enhance our understanding of the involvement of ILC2s in the development of AR in order to devise more effective approaches for its management. Consequently, targeted activation of ILC2s may prove to be an important approach for treating AR. In this review, we provide a concise overview of the pathogenesis involved in ILC2s-induced AR, along with an examination of existing and prospective therapeutic strategies (Table 1). Table 1 Clinical and Bas -Abstract Truncated-

Group 2 Innate Lymphoid Cells in Allergic Rhinitis

Research progress of group Ⅱ innate lymphoid cells in the allergic rhinitis

Angiotensin II Enhances Group 2 Innate Lymphoid Cell Responses Via AT1a During Airway Inflammation.

Allergic Inflammation is Exacerbated by Allergen-Induced Type 2 Innate Lymphoid Cells in a Murine Model of Allergic Rhinitis.

CD4+ T Cells Induce Productions of IL-5 and IL-13 Through MHCII on ILC2s in a Murine Model of Allergic Rhinitis.

Increased Expression of Type 2 Innate Lymphoid Cells in Pediatric Patients with Allergic Rhinitis.

ILC2s: Unraveling the Innate Immune Orchestrators in Allergic Inflammation

Increased Group 2 Innate Lymphoid Cells Are Correlated with Eosinophilic Granulocytes in Patients with Allergic Airway Inflammation

Role of autophagy and mitophagy of group 2 innate lymphoid cells in allergic and local allergic rhinitis

Increased Innate Type 2 Immune Response in House Dust Mite-Allergic Patients with Allergic Rhinitis

Modulating ILC2 function for treatment of type 2 airway diseases

Effects of Myeloid and Plasmacytoid Dendritic Cells on ILC2s in Patients with Allergic Rhinitis.

Leptin Regulated ILC2 Cell through the PI3K/AKT Pathway in Allergic Rhinitis

[Type 2 Innate Lymphoid Cells and Chronic Rhinosinusitis].

The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases

Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis

New insights into the function, development, and plasticity of type 2 innate lymphoid cells

IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response.

Comprehensive Analysis Reveals Hub Genes Associated with Immune Cell Infiltration in Allergic Rhinitis

Role of Th2, Th17 and Treg Cells and relevant cytokines in pathogenesis of allergic rhinitis

Update on pathomechanisms and treatments in allergic rhinitis